An unwanted guest came to our country during the last days of the year. A mutated virus that made the last days of the year a little bitter for the people. However, this bitterness did not disappoint health custodians in the country, who continued their efforts to control and prevent the disease.

According to the secretary of the biotechnology development headquarter, the clinical trials of the corona drug will be determined in the next two weeks.

Mostafa Ghanei, who is active as one of the members of the COVID-19 scientific committee, pointed out the production of corona-related drugs has been initiated in the country, adding: we have begun clinical trials of these drugs and will be ready in two weeks, and we will announce their full results in another month.

He also marked: these drugs are herbal and are intended to be used to treat corona disease. Of course, they have not yet received the final approval. These drugs are expected to undergo clinical testing after approval by the Food and Drug Administration of the Ministry of Health and Medical Education and we will provide results subsequently.

It is notable that “we will beat coronavirus with the help of the innovation and technology ecosystem” is the title of a call made to increase synergy among the players of the ecosystem to take an effective step toward helping the people and community in the combat against coronavirus using the abilities of knowledge-based companies and startups, as well as the scientific and technological capacity in the country.

A report by the public relations and information center of the Vice-Presidency for science and technology affairs